Skip to search formSkip to main contentSkip to account menu

RIG 200

Known as: RIG200 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

GlucosaminePenicillamine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
S‐Nitrosothiols cause prolonged, nitric oxide‐mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery
Reduced endothelial nitric oxide (NO) production in conduit vessels for coronary artery bypass grafting (CABG) has been… 
2000
2000
Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteries.
2000
2000
A novel S‐nitrosothiol (RIG200) causes prolonged relaxation in dorsal hand veins with damaged endothelium
Reduced nitric oxide bioavailability caused by endothelial dysfunction or damage is a contributory factor in the initiation and… 
2000
2000
Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryl trinitrate-tolerant rat femoral arteries.
1997
1997
Prolonged effect of a novel S‐nitrosated glyco‐amino acid in endothelium‐denuded rat femoral arteries: potential as a slow release nitric oxide donor drug
1 The vasodilator properties of a novel S‐nitrosated glyco‐amino acid (RIG200) were investigated in isolated rat femoral arteries… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)